PFE logo Pfizer +
Pfizer
+

Pfizer Overview

Company: Pfizer
CEO: Albert Bourla
Founded: 1849
Symbol: PFE
Exchange: NYSE
Industry: Drug Manufacturers - General
Sector: Healthcare
About

Pfizer discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas,luding cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas Pfizer was founded in 1849 and is headquartered in New York, New York.

Continue reading...

Pfizer (PFE)

  • Stock Price
  • Volume
25.75 -14.36 -35.80%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Pfizer annual revenue was $62.58 B in 2025.

Net Income

Pfizer annual net income was $7.77 B in 2025.

Employees

Pfizer annual employee count was 75,000 in 2025.

Revenue by Segment

Pfizer’s revenue by segment: Biopharma Segment: $61.20 B and Segment Reporting, Reconciling Item, Corporate Nonsegment: $1.38 B in 2025.

Revenue by Region

Pfizer’s revenue by region: Developed Rest Of World: $16.19 B, Emerging Markets: $9.31 B and UNITED STATES: $37.08 B in 2025.

Executive Salary

A. Bourla Chairman and Chief Executive Officer, at Pfizer, makes $27...

Revenue per Employee

Pfizer revenue per employee was $834.39 K in 2025.

Profit per Employee

Pfizer profit per employee was $103.60 K in 2025.

Income Statement

Operating Income

Pfizer annual operating income was $15.44 B in 2025.

Research & Development

Pfizer annual research & development expense was $11.98 B in 2025.

Tax Rate (%)

Pfizer annual Tax Rate was -4.00% in 2025.

Assets & Liabilities | Cash Flow

Total Assets

Pfizer annual total assets was - in 2025.

Total Liabilities

Pfizer annual total liabilities was -$93.10 B in 2025.

Capital Expenditure

Pfizer annual capital expenditures was - in 2025.

Ratios

Return on Equity (ROE)

Pfizer annual return on equity(ROE) was 8.35% in 2025.

Return on Assets (ROA)

Pfizer annual return on assets(ROA) was 0.00% in 2025.

Debt to Equity

Pfizer annual debt to equity was 77.96% in 2025.

Profitability

Gross Profit Margin (%)

Pfizer annual gross profit margin was 70.33% in 2025.

Operating Income Margin (%)

Pfizer annual operating income margin was 24.67% in 2025.

Net Income Margin (%)

Pfizer annual net income margin was 12.42% in 2025.

Earning Per Share

Pfizer annual earning per share was $1.37 in 2025.

EBITDA

Pfizer annual EBITDA was $15.10 B in 2025.

Free Cash Flow (FCF)

Pfizer annual free cash flow(FCF) was - in 2025.

Valuation

Enterprise value

Pfizer annual enterprise value was $141.50 B in 2025.

Enterprise value to Revenue

Pfizer annual enterprise value to revenue was 2.26 in 2025.

Enterprise value to EBITDA

Pfizer annual enterprise value to EBITDA was 9.37 in 2025.

Competitors’ Revenue

Frequently Asked Questions

When was Pfizer founded?

Pfizer was founded on 1849, which makes the company 177 years old.

Sign up for free to view

Who is the CEO of Pfizer?

Albert Bourla is the CEO of Pfizer.

What industry and sector is Pfizer in?

Pfizer operates in the Drug Manufacturers - General industry and the Healthcare sector.

What are Pfizer's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0000078003
  • SIC (Standard Industrial Classification): 2834
  • ISIN (International Securities Identification Number): US7170811035

Sign up for free to view

How many employees does Pfizer have?

Pfizer has 75,000 employees.

What is the revenue of Pfizer?

In fiscal year 2025, Pfizer generated a revenue of $62.58 Billion.

What is the net income of Pfizer?

In fiscal year 2025, Pfizer reported a net income of $7.77 Billion.

What is Pfizer's biggest product segment?

Biopharma Segment is Pfizer's biggest product segment, representing 97.79% of its total revenue.

When was Pfizer listed on the stock exchange?

Pfizer went public on Jun 1, 1972, through its Initial Public Offering (IPO), and it has been 53 years since then.

Sign up for free to view

What is the ticker symbol of Pfizer, and where is it listed?

Pfizer's ticker symbol is PFE, and the company is listed on the NYSE stock market exchange.

What is Pfizer's current stock price?

Pfizer's current stock price is $25.76 as of May 15, 2026.

What is Pfizer's market capitalization?

As of , Pfizer's market cap is .

What is Pfizer's ranking in the world?

Ranked #13among 2,808 companies based on market cap.

Who are the top competitors of Pfizer?

Competitors of Pfizer include Eli Lilly and Company, Johnson & Johnson and AbbVie, and more.

Related company

Submit feedback to Bullfincher